MFRCX
Price
$48.23
Change
-$0.41 (-0.84%)
Updated
Jul 13 closing price
Net Assets
7.94B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

MFRCX vs VFFSX

MFRCX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
MFRCX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFRCX is a StrongBuy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. MFRCX (7.94B). VFFSX pays higher dividends than MFRCX: VFFSX (1.08) vs MFRCX (0.00). MFRCX was incepted earlier than VFFSX: MFRCX (33 years) vs VFFSX (10 years). MFRCX (1.51) is less costly to investors than VFFSX (0.01). MFRCX is a more actively managed with annual turnover of: 41.00 vs. VFFSX (2.00). MFRCX has a lower initial minimum investment than VFFSX: MFRCX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. MFRCX (-4.31). VFFSX return over 5 years is better than : 73.48 vs. MFRCX (-6.89).
MFRCXVFFSXMFRCX / VFFSX
Total Expense Ratio1.500.0115,000%
Annual Report Gross Expense Ratio1.510.0115,100%
Fund Existence33 years10 years-
Gain YTD7.30210.68568%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets7.94B1.67T0%
Annual Yield % from dividends0.001.08-
Returns for 1 year-4.3121.07-20%
Returns for 3 years6.3968.459%
Returns for 5 years-6.8973.48-9%
Returns for 10 years39.00251.2116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6